{
    "organizations": [],
    "uuid": "8ba2a30c0bfad470333d62f793eef080c7e146cf",
    "author": "",
    "url": "https://www.reuters.com/article/brief-mabvax-receives-notice-of-sec-inve/brief-mabvax-receives-notice-of-sec-investigation-and-examination-of-certain-registration-statements-idUSFWN1PP123",
    "ord_in_thread": 0,
    "title": "BRIEF-Mabvax Receives Notice Of SEC Investigation And Examination Of Certain Registration Statements",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": " 14 PM / in 11 minutes BRIEF-Mabvax Receives Notice Of SEC Investigation And Examination Of Certain Registration Statements Reuters Staff \nJan 30 (Reuters) - Mabvax Therapeutics Holdings Inc : \n* MABVAX RECEIVES NOTICE OF SEC INVESTIGATION AND EXAMINATION OF CERTAIN REGISTRATION STATEMENTS \n* MABVAX THERAPEUTICS - RECEIVED NOTICE SEC WAS CONDUCTING INVESTIGATION RELATING TO CERTAIN OF COMPANYâ€˜S REGISTRATION STATEMENTS  ",
    "published": "2018-01-30T15:13:00.000+02:00",
    "crawled": "2018-01-30T15:32:05.018+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "pm",
        "minute",
        "receives",
        "notice",
        "sec",
        "investigation",
        "examination",
        "certain",
        "registration",
        "statement",
        "reuters",
        "staff",
        "jan",
        "reuters",
        "mabvax",
        "therapeutic",
        "holding",
        "inc",
        "mabvax",
        "receives",
        "notice",
        "sec",
        "investigation",
        "examination",
        "certain",
        "registration",
        "statement",
        "mabvax",
        "therapeutic",
        "received",
        "notice",
        "sec",
        "conducting",
        "investigation",
        "relating",
        "certain",
        "company",
        "registration",
        "statement"
    ]
}